Company Filing History:
Years Active: 2022-2025
Title: Emmanuel Suffert: Innovator in Pharmaceutical Chemistry
Introduction
Emmanuel Suffert is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of specific compounds. With a total of 3 patents to his name, Suffert continues to push the boundaries of drug development.
Latest Patents
Suffert's latest patents focus on crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide. The present invention describes specific crystalline forms of this compound, along with methods for preparing these forms. Additionally, it includes pharmaceutical compositions that comprise these crystalline forms and methods for using them to treat various diseases.
Career Highlights
Emmanuel Suffert is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Some of Suffert's notable coworkers include Stephanie Kay Dodd and Arnaud Grandeury. Their collaborative efforts have further enhanced the innovative research environment at Novartis.
Conclusion
Emmanuel Suffert's contributions to pharmaceutical chemistry through his patents and work at Novartis AG highlight his role as a key innovator in the industry. His ongoing research continues to pave the way for advancements in drug development and treatment options.